Fundz

Corvus Pharmaceuticals, Inc.

Burlingame, California, United States · Biopharma, Biotechnology, Healthcare

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company

You have opened 5 full company profiles today. Create an account to keep reading them. Create an account

Key facts

Headquarters
Burlingame, California, United States
Employees
Unknown
Industries
Biopharma, Biotechnology, Healthcare
Status
Public (CRVS)
Website
corvuspharma.com

Recent activity at Corvus Pharmaceuticals, Inc.

  • : SEC 8-K (5.02): On July 21, 2026, Ian T. Clark notified Corvus Pharmaceuticals, Inc. of his decision to resign from the board of directors, with his resignation effective as of July 22, 2026. Mr. Clark served on the board for over nine years, and the Company expressed gratitude for his significant contributions during his tenure. This change could impact the board's strategic direction and governance, as the Company will need to fill the vacancy left by Mr. Clark's departure following his extensive service.
  • : SEC 8-K (8.01):
  • : SEC 8-K (5.02): On April 22, 2026, Corvus Pharmaceuticals, Inc. appointed Andrew C. Chan, M.D., Ph.D., as a Class II director, effective April 23, 2026, with a term expiring at the 2027 annual meeting. Dr. Chan will receive a $35,000 annual retainer and an initial stock option grant of 30,000 shares under the company's 2016 Equity Incentive Award Plan, along with additional cash for serving on the Nominating Committee. Concurrently, Scott Morrison has notified the Board of his resignation, effective April 23, 2026, ending over a decade of service. This change highlights a shift in leadership dynamics within the Board.

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

About Corvus Pharmaceuticals, Inc.: questions and answers

What does Corvus Pharmaceuticals, Inc. do?

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company

Where is Corvus Pharmaceuticals, Inc. headquartered?

Corvus Pharmaceuticals, Inc. is headquartered in Burlingame, California, United States.

What is the latest news on Corvus Pharmaceuticals, Inc.?

On Apr 23, 2026, SEC 8-K (5.02): On July 21, 2026, Ian T. Clark notified Corvus Pharmaceuticals, Inc. of his decision to resign from the board of directors, with his resignation effective as of July 22, 2026. Mr. Clark served on the board for over nine years, and the Company expressed gratitude for his significant c

Is Corvus Pharmaceuticals, Inc. a public company?

Yes. Corvus Pharmaceuticals, Inc. is publicly traded under the ticker CRVS.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Corvus Pharmaceuticals, Inc. across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.